Composition
- Active ingredients
- THIOTEPA 15MG/VIAL
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- THIOTEPA 15MG/VIAL · InjectableANDA210337-001 · Prescription
- THIOTEPA 15MG/VIAL · InjectableANDA211831-001 · Prescription
- THIOTEPA 15MG/VIAL · InjectableNDA011683-001 · Discontinued
- THIOTEPA 15MG/VIAL · InjectableANDA209150-001 · Discontinued
- THIOTEPA 100MG/VIAL · PowderANDA213049-002 · Prescription
- THIOTEPA 15MG/VIAL · PowderANDA213049-001 · Prescription
- THIOTEPA 100MG/VIAL · PowderANDA214222-002 · Prescription
- THIOTEPA 15MG/VIAL · PowderANDA214222-001 · Prescription
- THIOTEPA 15MG/VIAL · PowderANDA216037-001 · Prescription
- THIOTEPA 100MG/VIAL · PowderANDA216037-002 · Prescription
- THIOTEPA 15MG/VIAL · InjectableANDA075698-001 · Discontinued
- THIOTEPA 15MG/VIAL · InjectableThis page
- THIOTEPA 15MG/VIAL · InjectableANDA075547-001 · Prescription
- THIOTEPA 15MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable
At a glance
- Brand name
- Thiotepa
- Route
- Injection
- Dosage form
- Injectable
- Applicant
- Penn Life
- Status
- Prescription
- FDA approval
- 10 Jan 2020
- Application
- ANDA208242-001